Gene Therapy Market - 2024-2033

June 2025 | 220 pages | ID: G017910498C0EN
DataM Intelligence

Abstracts

The Gene Therapy Market was valued at US$ 4.80 Billion in 2024 and is anticipated to reach US$ 35.91 Billion by 2033, at a CAGR of 0.231 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Gene Therapy Market.

This report delivers a comprehensive overview of the Gene Therapy Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Gene Therapy Market. The Gene Therapy Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

Gene Therapy Market Scope:

Key Players

• Spark Therapeutics, Inc.

Major Highlights

This report delivers a comprehensive overview of the Gene Therapy Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Gene Therapy Market. The Gene Therapy Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS

3.1. Key Trends and Future Projections

4. SNIPPET BY APPROACH

4.1. Snippet by Vector Type
4.2. Snippet by Technique

5. SNIPPET BY APPLICATION

5.1. Snippet by Region

6. DYNAMICS

6.1. Impacting Factors
  6.1.1. Drivers
    6.1.1.1. Expansion into the Rare Diseases
    6.1.1.2. Growing Utilization of Advanced Delivery Vectors
    6.1.1.3. XX
  6.1.2. Restraints
    6.1.2.1. High Cost associated with the Gene Therapies
    6.1.2.2. Safety and Long-Term Efficacy Concerns
    6.1.2.3. XX
  6.1.3. Opportunity
    6.1.3.1. Expansion into Complex & Chronic Diseases
    6.1.3.2. XX
  6.1.4. Impact Analysis

7. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

7.1. Market Leaders and Pioneers
  7.1.1. Emerging Pioneers and Prominent Players
  7.1.2. Established Leaders with the Largest Marketing Brand
  7.1.3. Market Leaders with Established Products
7.2. Latest Developments and Breakthroughs
7.3. Regulatory and Reimbursement Landscape
  7.3.1. North America
  7.3.2. Europe
  7.3.3. Asia Pacific
  7.3.4. South America
  7.3.5. Middle East & Africa
7.4. Porter’s Five Forces Analysis
7.5. Supply Chain Analysis
7.6. Patent Analysis
7.7. SWOT Analysis
7.8. Unmet Needs and Gaps
7.9. Recommended Strategies for Market Entry and Expansion
7.10. Pricing Analysis and Price Dynamics

8. GENE THERAPY MARKET, BY APPROACH

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Approach
  8.1.2. Market Attractiveness Index, By Approach
8.2. In-Vivo*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ex-vivo

9. GENE THERAPY MARKET, BY VECTOR TYPE

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Vector Type
  9.1.2. Market Attractiveness Index, By Vector Type
9.2. Viral Vectors*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  9.2.3. Adeno-Associated Virus
  9.2.4. Herpes Simplex Virus
  9.2.5. Lentivirus
9.3. Non-Viral Vectors

10. GENE THERAPY MARKET, BY TECHNIQUE

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
  10.1.2. Market Attractiveness Index, By Technique
10.2. Gene Addition*
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Gene Silencing
10.4. Gene Editing

11. GENE THERAPY MARKET, BY APPLICATION

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  11.1.2. Market Attractiveness Index, By Application
11.2. Rare Diseases*
  11.2.1. Introduction
  11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Musculoskeletal Conditions
11.4. Blood Disorders
11.5. Oncology
11.6. Ophthalmology
11.7. Others

12. GENE THERAPY MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

13. INTRODUCTION

13.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  13.1.1. Market Attractiveness Index, By Region
13.2. North America
  13.2.1. Introduction
  13.2.2. Key Region-Specific Dynamics
  13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Approach
  13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Vector Type
  13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
  13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.2.7.1. U.S.
    13.2.7.2. Canada
    13.2.7.3. Mexico
13.3. Europe
  13.3.1. Introduction
  13.3.2. Key Region-Specific Dynamics
  13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Approach
  13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Vector Type
  13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
  13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.3.7.1. Germany
    13.3.7.2. UK
    13.3.7.3. France
    13.3.7.4. Spain
    13.3.7.5. Italy
    13.3.7.6. Rest of Europe
13.4. Asia-Pacific
  13.4.1. Introduction
  13.4.2. Key Region-Specific Dynamics
  13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Approach
  13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Vector Type
  13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
  13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.4.7.1. China
    13.4.7.2. India
    13.4.7.3. Japan
    13.4.7.4. South Korea
    13.4.7.5. Rest of Asia-Pacific
13.5. South America
  13.5.1. Introduction
  13.5.2. Key Region-Specific Dynamics
  13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Approach
  13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Vector Type
  13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
  13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.5.7.1. Brazil
    13.5.7.2. Argentina
    13.5.7.3. Rest of South America
13.6. Middle East and Africa
  13.6.1. Introduction
  13.6.2. Key Region-Specific Dynamics
  13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Approach
  13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Vector Type
  13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
  13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

14. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

15. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS

15.1. Market Share Analysis and Positioning Matrix
15.2. Strategic Partnerships, Mergers & Acquisitions
15.3. Key Developments in Product Portfolios and Innovations
15.4. Company Benchmarking

16. COMPANY PROFILES

16.1. Spark Therapeutics, Inc.*
  16.1.1. Company Overview
  16.1.2. Product Portfolio
    16.1.2.1. Product Description
    16.1.2.2. Product Key Performance Indicators (KPIs)
    16.1.2.3. Historic and Forecasted Product Sales
    16.1.2.4. Product Sales Volume

17. FINANCIAL OVERVIEW

17.1. Company Revenue
  17.1.1. Geographical Revenue Shares
    17.1.1.1. Revenue Forecasts
  17.1.2. Key Developments
    17.1.2.1. Mergers & Acquisitions
    17.1.2.2. Key Product Development Activities
    17.1.2.3. Regulatory Approvals, etc.
  17.1.3. SWOT Analysis
17.2. Novartis AG
17.3. bluebird bio, Inc.
17.4. Ferring Pharmaceuticals Inc.
17.5. Vertex Pharmaceuticals Incorporated
17.6. Sarepta Therapeutics, Inc.
17.7. CSL Behring LLC
17.8. Alnylam Pharmaceuticals, Inc.
17.9. Amgen, Inc.
17.10. Orchard Therapeutics group.
17.11. Krystal Biotech, Inc.LIST NOT EXHAUSTIVE

18. ASSUMPTION AND RESEARCH METHODOLOGY

18.1. Data Collection Methods
18.2. Data Triangulation
18.3. Forecasting Techniques
18.4. Data Verification and Validation

19. APPENDIX

19.1. About Us and Services
19.2. Contact Us